[HTML][HTML] Systematic validation of variants of unknown significance in APP, PSEN1 and PSEN2
Alzheimer's disease (AD) is a neurodegenerative disease that is clinically characterized by
progressive cognitive decline. More than 200 pathogenic mutations have been identified in …
progressive cognitive decline. More than 200 pathogenic mutations have been identified in …
LMNA‐mediated nucleoskeleton dysregulation in Alzheimer disease
Background Nucleoskeleton dysfunction has been implicated in Alzheimer disease (AD).
Tubular invaginations of the nuclear envelope observed in AD brains are consistent with the …
Tubular invaginations of the nuclear envelope observed in AD brains are consistent with the …
Defining the role of PLD3 in Alzheimer's disease pathology
MJ Rosene, S Hsu, R Martinez, J Norton… - Alzheimer's & …, 2021 - Wiley Online Library
Background Alzheimer’s disease (AD) is characterized by the accumulation of amyloid‐β (Aβ)
in the brain. We recently identified coding variants in the phospholipase D3 (PLD3) gene …
in the brain. We recently identified coding variants in the phospholipase D3 (PLD3) gene …
Phospholipase D3 contributes to Alzheimer's disease risk via disruption of Aβ clearance and microglia response to amyloid plaques
Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β (Aβ) plaques
and neurofibrillary tangles in the brain. AD is also the result of complex genetic architecture …
and neurofibrillary tangles in the brain. AD is also the result of complex genetic architecture …
Phospholipase D3 drives microglial response to amyloid pathology in Alzheimer's disease
Background Amyloid‐beta (Aβ) plaque formation is a well‐established hallmark for Alzheimer’s
disease (AD). However, the processes behind plaque formation are not understood. …
disease (AD). However, the processes behind plaque formation are not understood. …
A cell‐autonomous role of DNAJC5 in microglial‐mediated proteostasis in Alzheimer's disease
Background DNAJC5 encodes co‐chaperone cysteine‐string protein alpha (CSPα), a
synaptic and endolysosomal protein whose mutations cause adult‐onset neuronal ceroid …
synaptic and endolysosomal protein whose mutations cause adult‐onset neuronal ceroid …
Defining the role of PLD3 in Alzheimer disease pathology
MJ Rosene, S Hsu, R Martinez, J Norton… - Alzheimer's & …, 2021 - Wiley Online Library
Background Alzheimer’s disease (AD) is characterized by the accumulation of amyloid‐β (Aβ)
in the brain. We recently identified coding variants in the phospholipase D3 (PLD3) gene …
in the brain. We recently identified coding variants in the phospholipase D3 (PLD3) gene …
Comparison of concussion rates between NCAA Division I and Division III men's and women's ice hockey players
JM Rosene, B Raksnis, B Silva… - … American Journal of …, 2017 - journals.sagepub.com
Background: Examinations related to divisional differences in the incidence of sports-related
concussions (SRC) in collegiate ice hockey are limited. Purpose: To compare the …
concussions (SRC) in collegiate ice hockey are limited. Purpose: To compare the …
Defining the role of rare genetic variants that drive risk and pathogenesis of Alzheimer's disease
MJ Rosene - 2022 - search.proquest.com
Alzheimer’s disease (AD) is the leading cause of dementia and is pathologically defined by
the aggregation of extracellular amyloid plaques and intracellular neurofibrillary tangles. …
the aggregation of extracellular amyloid plaques and intracellular neurofibrillary tangles. …
[BOOK][B] Thinking ecologically about the global political economy
R Katz-Rosene, M Paterson - 2018 - taylorfrancis.com
… © 2018 Ryan Katz- Rosene and Matthew Paterson The right of Ryan Katz- Rosene and
Matthew Paterson to be identified as authors of this work has been asserted by them in …
Matthew Paterson to be identified as authors of this work has been asserted by them in …
